Lux Health Tech Acquisition Corp. Units
LUXAU
LUXAU was delisted on the 27th of October, 2022.
47 hedge funds and large institutions have $264M invested in Lux Health Tech Acquisition Corp. Units in 2020 Q4 according to their latest regulatory filings, with 47 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCP
D1 Capital Partners
New York
|
+$32.2M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$23.6M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$16M |
| 4 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$14.9M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$13.4M |
Top Sellers
LUXAU Hedge Fund Activity: Q4 2020 in Review
47 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Units (LUXAU) for Q4 2020, worth a combined $264M.
Buyers outnumbered sellers: 47 funds opened new LUXAU positions and 0 closed out — a net gain of 47 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was D1 Capital Partners, opening a new position worth an estimated $32.2M.
- 47 institutional investors held Lux Health Tech Acquisition Corp. Units (LUXAU) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $264M of Lux Health Tech Acquisition Corp. Units stock for Q4 2020.
- 47 funds opened new Lux Health Tech Acquisition Corp. Units positions in Q4 2020 and 0 closed out, a net change of +47 holders.
- The largest Lux Health Tech Acquisition Corp. Units buyer in Q4 2020 was D1 Capital Partners, an estimated $32.2M added.
Based on aggregated 13F filings for Q4 2020.